【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Glaucoma Overview 11
Therapeutics Development 12
Pipeline Products for Glaucoma – Overview 12
Pipeline Products for Glaucoma – Comparative Analysis 13
Glaucoma – Therapeutics under Development by Companies 14
Glaucoma – Therapeutics under Investigation by Universities/Institutes 18
Glaucoma – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Unknown Stage Products 22
Glaucoma – Products under Development by Companies 23
Glaucoma – Products under Investigation by Universities/Institutes 29
Glaucoma – Companies Involved in Therapeutics Development 30
AC Immune SA 30
Acadia Pharmaceuticals Inc. 31
Aerie Pharmaceuticals, Inc. 32
Alcon, Inc. 33
Allergan, Inc. 34
Altacor Ltd. 35
Amakem NV 36
Asahi Kasei Pharma Corp. 37
AUS Bio Limited 38
Bausch & Lomb Incorporated 39
Bionure Farma, S.L. 40
Can-Fite BioPharma Ltd. 41
Cellular Biomedicine Group, Inc. 42
China Grand Wuhan General Pharmaceutical Research Institute 43
D. Western Therapeutics Institute, Inc. 44
DNAVEC Corporation 45
Dompe Farmaceutici S.p.A. 46
F. Hoffmann-La Roche Ltd. 47
Foamix Pharmaceuticals Ltd. 48
Gene Signal International SA 49
Gilead Sciences, Inc. 50
Handok Inc. 51
High Point Pharmaceuticals, LLC 52
Icon Bioscience, Inc. 53
IMMD Inc. 54
Inotek Pharmaceuticals Corporation 55
InSite Vision Incorporated 56
Lacer, S.A. 57
Merck & Co., Inc. 58
Merz Pharma GmbH & Co. KgaA 59
Mimetogen Pharmaceuticals Inc. 60
NeoStem, Inc. 61
Neurotech Pharmaceuticals, Inc. 62
NicOx S.A. 63
Ocata Therapeutics, Inc. 64
Ocular Therapeutix, Inc. 65
Ohr Pharmaceutical Inc. 66
Ono Pharmaceutical Co., Ltd. 67
Otsuka Holdings Co., Ltd. 68
Oxford BioMedica plc 69
PharmaNova Inc. 70
Quark Pharmaceuticals, Inc. 71
Santen Pharmaceutical Co., Ltd. 72
Senju Pharmaceutical Co., Ltd. 73
SIFI S.p.A 74
SK Biopharmaceuticals Co., Ltd. 75
Sun Pharma Advanced Research Company Ltd. 76
Sylentis S.A. 77
Teva Pharmaceutical Industries Limited 78
Upsher-Smith Laboratories, Inc. 79
Glaucoma – Therapeutics Assessment 80
Assessment by Monotherapy Products 80
Assessment by Combination Products 81
Assessment by Target 82
Assessment by Mechanism of Action 86
Assessment by Route of Administration 90
Assessment by Molecule Type 92
Drug Profiles 94
(AR-13324 + latanoprost) – Drug Profile 94
(bimatoprost + brimonidine tartrate) – Drug Profile 95
(carteolol hydrochloride + latanoprost) – Drug Profile 96
(dorzolamide hydrochloride + latanoprost) – Drug Profile 97
(latanoprost + trabodenoson) – Drug Profile 98
(Prostaglandin Agonist + Beta-Blocker) – Drug Profile 99
(tafluprost + timolol maleate) – Drug Profile 100
AC-262271 – Drug Profile 101
ACI-260 – Drug Profile 102
ACN-1052 – Drug Profile 103
aganirsen – Drug Profile 104
ALT-022 – Drug Profile 106
AMA-0076 – Drug Profile 107
Antibody to Inhibit Sema3A for Glaucoma and Optic Neuropathy – Drug Profile 108
AP-022 – Drug Profile 109
APH-1104 – Drug Profile 110
AR-13324 – Drug Profile 111
AR-13533 – Drug Profile 112
ATS-8535 – Drug Profile 113
BA-1049 – Drug Profile 114
BA-240 – Drug Profile 115
bimatoprost – Drug Profile 116
bimatoprost SR – Drug Profile 117
BN-201 – Drug Profile 118
CF-101 – Drug Profile 119
CNS-102 – Drug Profile 122
DE-117 – Drug Profile 123
dorzolamide hydrochloride nanoparticle – Drug Profile 124
Drugs for Steroid Induced Glaucoma – Drug Profile 125
Drugs to Inhibit Cadherin-5 for Glaucoma – Drug Profile 126
Drugs to Target Bestrophin-2 for Glaucoma – Drug Profile 127
ENV-515 – Drug Profile 128
GB-201 – Drug Profile 129
GB-202 – Drug Profile 130
GB-203 – Drug Profile 131
GB-204 – Drug Profile 132
Gene Therapy for Glaucoma and Retinitis Pigmentosa – Drug Profile 133
Gene Therapy for Ocular Diseases – Drug Profile 134
Gene Therapy for Steroid Induced Glaucoma and Ocular Hypertension – Drug Profile 135
Glaucoma-GT – Drug Profile 136
GS-607601 – Drug Profile 137
H-1129 – Drug Profile 138
H-1129 Backup – Drug Profile 139
HL-5521 – Drug Profile 140
HPP-851 – Drug Profile 141
IMD-1041 – Drug Profile 142
KR-12 – Drug Profile 143
LA-8045 – Drug Profile 144
latanoprost – Drug Profile 145
latanoprost – Drug Profile 146
latanoprost – Drug Profile 148
latanoprost – Drug Profile 149
latanoprost SR – Drug Profile 150
latanoprostene bunod – Drug Profile 152
lomerizine – Drug Profile 154
Lycium Anti-Angiogenic Proteoglycan – Drug Profile 155
MD-920G – Drug Profile 156
MIMD-3 – Drug Profile 157
minocycline Gel – Drug Profile 158
Monoclonal Antibody to Activate Bves for Glaucoma – Drug Profile 159
MRZ-99030 – Drug Profile 160
NB-1111 – Drug Profile 161
NCX-1021 – Drug Profile 162
NCX-250 – Drug Profile 163
Neurovitas – Drug Profile 164
NT-501 – Drug Profile 165
NT-509 – Drug Profile 167
ONO-9054 – Drug Profile 168
OPA-6566 – Drug Profile 169
PBF-695 – Drug Profile 170
PRX-00933 – Drug Profile 171
QPI-1007 – Drug Profile 172
R-807 – Drug Profile 173
Recombinant Human Nerve Growth Factor – Drug Profile 174
RO-5093151 – Drug Profile 175
SF-103 – Drug Profile 177
SF-108 – Drug Profile 178
SF-109 – Drug Profile 179
SF-116 – Drug Profile 180
SKL-G – Drug Profile 181
SKS-1002 – Drug Profile 182
Small Molecule for Glaucoma – Drug Profile 183
Small Molecule for Glaucoma – Drug Profile 184
Small Molecule to Inhibit Rho Kinase for Glaucoma – Drug Profile 185
Small Molecule to Inhibit Sema3A for Glaucoma and Optic Neuropathy – Drug Profile 186
Small Molecules for CNS Disorders and Ophthalmology – Drug Profile 187
Small Molecules to Activate sGC for Ophthalmology – Drug Profile 188
Small Molecules to Antagonize TRPM7 for Myocardial Ischemia and Glaucoma – Drug Profile 189
Small Molecules to Antagonize TRPV4 for Glaucoma – Drug Profile 190
Small Molecules to Inhibit LIMK1 AND LIMK2 for Cancer and Ophthalmology – Drug Profile 191
SNJ-1656 – Drug Profile 192
SNJ-1945 – Drug Profile 194
Stem Cell Therapy for Glaucoma – Drug Profile 195
Stem Cell Therapy for Glaucoma, Cerebral Palsy and Lupus – Drug Profile 196
Stem Cell Therapy for Macular Degeneration and Glaucoma – Drug Profile 197
Stem Cell Therapy for Ophthalmic Disorders – Drug Profile 198
SYL-040012 – Drug Profile 199
Synthetic Peptide for Glaucoma – Drug Profile 201
tafluprost – Drug Profile 202
trabodenoson – Drug Profile 204
travoprost SR – Drug Profile 205
TRV-32R – Drug Profile 206
XY-0811QF2 – Drug Profile 207
XY-1303LT2 – Drug Profile 208
Glaucoma – Recent Pipeline Updates 209
Glaucoma – Dormant Projects 230
Glaucoma – Discontinued Products 232
Glaucoma – Product Development Milestones 233
Featured News & Press Releases 233
Appendix 242
Methodology 242
Coverage 242
Secondary Research 242
Primary Research 242
Expert Panel Validation 242
Contact Us 243
Disclaimer 243
【レポート販売概要】
■ タイトル：緑内障(Glaucoma)の治療薬パイプライン動向（2015年上半期版）■ 英文：Glaucoma - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6016IDB
■ 調査対象地域：グローバル
- Mitral Regurgitation：グローバル臨床試験レビューH1, 2013Mitral Regurgitation Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Mitral Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Mitral Regurgitation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mitral Regurgitation. It includes an overview of the trial numbers and their r …
- 交通カードの世界市場2016-2020About the Transit Cards Market The increase in population and urbanization has resulted in the growing need for mobility. Public transportation has become the most preferred mode of transportation for people to avoid problems such as air pollution and traffic congestion. Traveling by buses, trains, and metros is often more comfortable, convenient, and cost-effective. To make traveling for people m …
- 世界のモバイルNANDフラッシュメモリ市場動向（2014-2018）TechNavio’s analysts forecast the Global Mobile NAND Flash Memory market to grow at a CAGR of 18.8 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high demand for smartphones across the globe. The Global Mobile NAND Flash Memory has also been witnessing the rapid technological advancements. However, the high inventory levels in the supply chain c …
- 液体分配装置の世界市場分析：製品別（フラックス、潤滑剤、はんだペースト、接着剤およびシーラント（エポキシ接着剤、エポキシアンダーフィル）、絶縁保護コーティング）、用途別（電気・電子（半導体実装、プリント基板）、医療機器、自動車、建設）、セグメント予測The global fluid dispensing systems market is expected to reach USD 55.09 billion by 2024, according to a new report by Grand View Research, Inc. Growing electronic components manufacturing in Southeast Asia to drive growth. The trend towards miniaturization of electronic components and industry automation are key growth driving factors for the global fluid dispensing systems market. Recent innova …
- ティー（茶）の世界市場2016-2020About Tea Market After water, tea is consumed the most, and it also costs less compared to other beverages. It contains large amounts of antioxidants, and it can thus help in lowering the risk of various health problems. It helps to treat cancer, prevents arthritis, boosts bone density, controls blood pressure, and reduces the risk of heart diseases. Green tea, especially, contains antioxidants an …
- 悪性神経膠腫(Malignant Glioma)の治療薬パイプライン動向（2015年上半期版）Malignant Glioma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of …
- 軍事用UAV（無人機）の世界市場2016-2026Visiongain’s comprehensive new 342 page report reveals that global expenditure on military UAVs will achieve revenues of $7,447m in 2016. Are you involved in the military UAV market or intend to be? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: Military unmanned aerial vehicles (UAV) are airborne platforms that do not …
- RFテスト機器の世界市場2016-2020About RF Test Equipment RF test equipment is used to measure the amount of RF waves emitted by a particular device. It includes traditional and modular general-purpose (GP) instruments and semiconductor automated test equipment (ATE). Traditional GP instrumentation is classified into spectrum analyzers, signal generators, electronic counters, power meters, network analyzers, one-box testers, and c …
- 世界のデジタルX線装置（医療機器）市場（～2018）The global digital X-ray market is categorized on the basis of application, technology, portability, product, end user, price, and geography. The mammography market is expected to register the highest growth rate in the digital X-ray market by application, during the forecast period. This high growth is attributed to technological advancements and the rising incidences of breast cancer .Chest imag …
- Tardive Dyskinesia：グローバル臨床試験レビューH1, 2013Tardive Dyskinesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2013" provides data on the Tardive Dyskinesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tardive Dyskinesia. It includes an overview of the trial numbers and their recruitme …
- 世界の骨粗鬆症治療薬（Osteoporosis Drugs）市場動向（2014-2018）TechNavio's analysts forecast the Global Osteoporosis Drugs market to grow at a CAGR of 3.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Osteoporosis Drugs market has also been witnessing the increasing awareness of bone health education. However, the multiple patent expiries could pose a challen …
- 金属製パッケージ（包装容器）の世界市場：アルミニウム製容器、スチール製容器、ブリキ製容器About Metal Packaging Packaging, in broader terms, refers to the technology of enclosing a product for the purpose of storage, distribution, sale, and use. Metal packaging is an essential constituent of Industrial products, such as adhesives, coatings, inks, and paints. During the entire product lifecycle, it withstands the chemical formulations and guards the product from exposure to light, air, …
- 世界のナノコーティング市場：自動車産業用途Surface protection is a key area in the automobile market both for protection from UV, wear, heat; promotion of adhesion; and reduction of engine friction. The overall world automotive paints and coatings market was estimated to be $7.75billion in 2010 and nanomaterials will play a key role in future growth. Desirable functional properties for the automotive coatings industry afforded by nanomater …
- 食品・飲料産業用ロボットの世界市場2015-2019[Global Industrial Robotics Market in Food and Beverage Industry 2015-2019] Covering: Segmentation of the global industrial robotics market in the food and beverage industry by type (articulated, Cartesian, SCARA, and delta), by application (palletizing, packaging, pick and place, and processing), and by geography (the Americas, EMEA, and APAC). ABB, FANUC, Kawasaki Robotics, KUKA, and Yaskawa Ele …
- 世界の教育分野におけるクラウド・コンピューティング市場予測と分析(2014-2019)For the past few years, the market for cloud has developed and has adopted the latest trends with increasing demand among schools and colleges.This market involvesthe recent implementation of cloud services and software applications through cloud deployment models to create an innovative learning environment. The cloud computing market in education is defined as the summation ofcloud service model …
